CAS |
No.60-32-2 |
中文名称 |
6-氨基正己酸 |
英文名称 |
6-Aminocaproic Acid |
别名 |
抗血纤溶酸;氨基己酸 |
分子式 |
C6H13NO2 |
分子量 |
131.17 |
溶解性 |
Soluble in Water ≥250mg/mL |
纯度 |
≥98% |
级别 |
Cell Culture |
外观(性状) |
White to off-white Solid |
储存条件 |
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
运输条件 |
冷藏运输 |
EC |
EINECS 200-469-3 |
MDL |
MFCD00008238 |
SMILES |
O=C(O)CCCCCN |
InChIKey |
SLXKOJJOQWFEFD-UHFFFAOYSA-N |
InChI |
InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9) |
PubChem CID |
564 |
靶点 |
Others |
通路 |
Others |
背景说明 |
6-Aminocaproic Acid是一种单氨基羧酸,是一种有效的、具有口服活性的纤溶酶和纤溶酶原的抑制剂。6-Aminocaproic Acid是一种有效的抗纤维蛋白溶解剂,能够竞争性结合纤溶酶原上的赖氨酸残基,防止血块溶解,并抑制纤溶酶的形成,减少纤维蛋白溶解。6-Aminocaproic Acid可用于出血性疾病的研究。 |
生物活性 |
6-Aminocaproic acid (EACA), a monoamino carboxylic acid, is a potent and orally active inhibitor of plasmin and plasminogen. 6-Aminocaproic acid is a potent antifibrinolytic agent. 6-Aminocaproic acid prevents clot lysis through the competitive binding of lysine residues on plasminogen, inhibiting plasmin formation and reducing fibrinolysis. 6-Aminocaproic acid can be used for the research of bleeding disorders[1-2]. |
In Vitro |
EACA(20-180 μg/mL)inhibits fibrinolysis in plasma of Asian elephants,with an effective concentration of 61.5 μg/mL[2]. |
In Vivo |
EACA(20-100 mg/kg; a single p.o.)inhibits fibrinolysis at all doses tested in dogs.EACA(20-100 mg/kg; a single p.o.)is rapidly absorbed(Tmax=1 h)and eliminated rapidly in dogs[3]. |
数据来源文献 |
[1]. Griffin JD, et, al. Epsilon-aminocaproic acid (EACA). Semin Thromb Hemost. Summer 1978;5(1):27-40. [2]. Kaye S, et, al. EFFECT OF ε-AMINOCAPROIC ACID ON FIBRINOLYSIS IN PLASMA OF ASIAN ELEPHANTS (ELEPHAS MAXIMUS). J Zoo Wildl Med. 2016 Jun;47(2):397-404. [3]. Brown JC, et, al. Effect of aminocaproic acid on clot strength and clot lysis of canine blood determined by use of an in vitro model of hyperfibrinolysis. Am J Vet Res. 2016 Nov;77(11):1258-1265. |
规格 |
10mg 50mg 100mg |
单位 |
瓶 |